Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 1
1947 2
1951 1
1964 1
1965 1
1966 2
1968 1
1969 1
1970 3
1971 3
1972 1
1976 1
1977 1
1978 1
1979 1
1980 1
1986 2
1987 1
1988 1
1989 1
1990 4
1991 1
1992 5
1993 1
1994 4
1995 7
1996 10
1997 6
1998 3
1999 5
2000 3
2001 3
2002 6
2003 2
2004 5
2005 4
2006 11
2007 17
2008 16
2009 14
2010 10
2011 15
2012 21
2013 23
2014 23
2015 16
2016 19
2017 26
2018 31
2019 37
2020 37
2021 33
2022 21
2023 13

Text availability

Article attribute

Article type

Publication date

Search Results

425 results

Results by year

Filters applied: . Clear all
Page 1
Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors.
Strosberg J, El-Haddad G, Wolin E, Hendifar A, Yao J, Chasen B, Mittra E, Kunz PL, Kulke MH, Jacene H, Bushnell D, O'Dorisio TM, Baum RP, Kulkarni HR, Caplin M, Lebtahi R, Hobday T, Delpassand E, Van Cutsem E, Benson A, Srirajaskanthan R, Pavel M, Mora J, Berlin J, Grande E, Reed N, Seregni E, Öberg K, Lopera Sierra M, Santoro P, Thevenet T, Erion JL, Ruszniewski P, Kwekkeboom D, Krenning E; NETTER-1 Trial Investigators. Strosberg J, et al. Among authors: kulkarni hr. N Engl J Med. 2017 Jan 12;376(2):125-135. doi: 10.1056/NEJMoa1607427. N Engl J Med. 2017. PMID: 28076709 Free PMC article. Clinical Trial.
Feasibility, Biodistribution, and Preliminary Dosimetry in Peptide-Targeted Radionuclide Therapy of Diverse Adenocarcinomas Using 177Lu-FAP-2286: First-in-Humans Results.
Baum RP, Schuchardt C, Singh A, Chantadisai M, Robiller FC, Zhang J, Mueller D, Eismant A, Almaguel F, Zboralski D, Osterkamp F, Hoehne A, Reineke U, Smerling C, Kulkarni HR. Baum RP, et al. Among authors: kulkarni hr. J Nucl Med. 2022 Mar;63(3):415-423. doi: 10.2967/jnumed.120.259192. Epub 2021 Jun 24. J Nucl Med. 2022. PMID: 34168013 Free PMC article.
Cystic fibrosis revisited.
Kulkarni H, Kansra S, Karande S. Kulkarni H, et al. J Postgrad Med. 2019 Oct-Dec;65(4):193-196. doi: 10.4103/jpgm.JPGM_263_18. J Postgrad Med. 2019. PMID: 31169132 Free PMC article. No abstract available.
Lung epithelial cell-derived C3 protects against pneumonia-induced lung injury.
Sahu SK, Ozantürk AN, Kulkarni DH, Ma L, Barve RA, Dannull L, Lu A, Starick M, McPhatter J, Garnica L, Sanfillipo-Burchman M, Kunen J, Wu X, Gelman AE, Brody SL, Atkinson JP, Kulkarni HS. Sahu SK, et al. Among authors: kulkarni hs. Sci Immunol. 2023 Feb 3;8(80):eabp9547. doi: 10.1126/sciimmunol.abp9547. Epub 2023 Feb 3. Sci Immunol. 2023. PMID: 36735773
Prostate-Specific Membrane Antigen Radioligand Therapy Using 177Lu-PSMA I&T and 177Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer: Comparison of Safety, Biodistribution, and Dosimetry.
Schuchardt C, Zhang J, Kulkarni HR, Chen X, Müller D, Baum RP. Schuchardt C, et al. Among authors: kulkarni hr. J Nucl Med. 2022 Aug;63(8):1199-1207. doi: 10.2967/jnumed.121.262713. Epub 2021 Dec 9. J Nucl Med. 2022. PMID: 34887335 Free PMC article.
The Author Reply.
Omar AMS, Lancaster MC, Narula S, Kulkarni H, Narula J, Sengupta PP. Omar AMS, et al. Among authors: kulkarni h. JACC Cardiovasc Imaging. 2020 Jan;13(1 Pt 2):337-338. doi: 10.1016/j.jcmg.2019.08.021. JACC Cardiovasc Imaging. 2020. PMID: 31918903 Free article. No abstract available.
Update on the Features and Measurements of Experimental Acute Lung Injury in Animals: An Official American Thoracic Society Workshop Report.
Kulkarni HS, Lee JS, Bastarache JA, Kuebler WM, Downey GP, Albaiceta GM, Altemeier WA, Artigas A, Bates JHT, Calfee CS, Dela Cruz CS, Dickson RP, Englert JA, Everitt JI, Fessler MB, Gelman AE, Gowdy KM, Groshong SD, Herold S, Homer RJ, Horowitz JC, Hsia CCW, Kurahashi K, Laubach VE, Looney MR, Lucas R, Mangalmurti NS, Manicone AM, Martin TR, Matalon S, Matthay MA, McAuley DF, McGrath-Morrow SA, Mizgerd JP, Montgomery SA, Moore BB, Noël A, Perlman CE, Reilly JP, Schmidt EP, Skerrett SJ, Suber TL, Summers C, Suratt BT, Takata M, Tuder R, Uhlig S, Witzenrath M, Zemans RL, Matute-Bello G. Kulkarni HS, et al. Am J Respir Cell Mol Biol. 2022 Feb;66(2):e1-e14. doi: 10.1165/rcmb.2021-0531ST. Am J Respir Cell Mol Biol. 2022. PMID: 35103557 Free PMC article.
Worker equity in renal medicine.
Kulkarni H, Hughes JT. Kulkarni H, et al. Intern Med J. 2022 Nov;52(11):1859-1862. doi: 10.1111/imj.15944. Intern Med J. 2022. PMID: 36404114 No abstract available.
425 results